We are live on ! Find out more
ALLK

Allakos

Delisted

ALLK was delisted on the 15th of May, 2025.

74 hedge funds and large institutions have $1.09B invested in Allakos in 2019 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 32 increasing their positions, 17 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 17

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

40% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 10

18% more capital invested

Capital invested by funds: $927M → $1.09B (+$166M)

3% more funds holding

Funds holding: 7274 (+2)

96% less call options, than puts

Call options by funds: $42K | Put options by funds: $975K

Holders
74
Holders Change
+2
Holders Change %
+2.78%
% of All Funds
1.61%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
14
Increased
32
Reduced
17
Closed
10
Calls
$42K
Puts
$975K
Net Calls
-$933K
Net Calls Change
-$933K
Name Holding Trade Value Shares
Change
Change in
Stake
Capital Research Global Investors
1
Capital Research Global Investors
California
$183M +$1.07M +26,191 +0.6%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$175M +$2.41M +58,615 +1%
RG
3
Redmile Group
California
$99.7M +$19.1M +465,891 +25%
NMC
4
NEA Management Company
Maryland
$98.3M
Capital World Investors
5
Capital World Investors
California
$96.5M +$91.4M +2,227,447 New
BlackRock
6
BlackRock
New York
$80.9M +$6.26M +152,634 +9%
Vanguard Group
7
Vanguard Group
Pennsylvania
$75.2M +$3.64M +88,745 +5%
Capital International Investors
8
Capital International Investors
California
$69.5M +$9.24M +225,275 +16%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$30.6M -$2.47M -60,126 -8%
CAM
10
Cormorant Asset Management
Massachusetts
$28.2M -$4.1M -100,000 -13%
AllianceBernstein
11
AllianceBernstein
Tennessee
$21.8M +$3.15M +76,868 +18%
BC
12
Boxer Capital
California
$20.6M -$13.3M -324,000 -41%
SB
13
Samsara BioCapital
California
$18.9M
RSCM
14
Rock Springs Capital Management
Maryland
$17.5M
State Street
15
State Street
Massachusetts
$13.8M -$22.5M -547,917 -63%
DCM
16
Driehaus Capital Management
Illinois
$10.8M +$3.01M +73,400 +42%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$7.69M +$470K +11,461 +7%
Northern Trust
18
Northern Trust
Illinois
$7.37M +$158K +3,847 +2%
AA
19
ALPS Advisors
Colorado
$3.89M +$3.69M +89,860 New
N
20
Nuveen
North Carolina
$3.11M +$2.95M +71,791 New
Charles Schwab
21
Charles Schwab
California
$2.85M +$403K +9,825 +18%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$2.59M +$286K +6,967 +13%
Victory Capital Management
23
Victory Capital Management
Texas
$2.5M +$503K +12,250 +27%
Goldman Sachs
24
Goldman Sachs
New York
$2.46M -$121K -2,940 -5%
GGHC
25
Gilder Gagnon Howe & Co
New York
$1.4M -$3.37K -82 -0.3%

ALLK Hedge Fund Activity: Q2 2019 in Review

74 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Allakos (ALLK) for Q2 2019, worth a combined $1.09B — up 18% from $927M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ALLK positions and 10 closed out — a net gain of 4 holders — while 32 added to existing stakes and 17 trimmed.

The largest buyer was Capital World Investors, opening a new position worth an estimated $91.4M. The largest seller was State Street, cutting an estimated $22.5M.

  • 74 institutional investors held Allakos (ALLK) as of Q2 2019, up from 72 in Q1 2019.
  • Funds reported $1.09B of Allakos stock for Q2 2019, up 18% quarter-over-quarter.
  • 14 funds opened new Allakos positions in Q2 2019 and 10 closed out, a net change of +4 holders.
  • The largest Allakos buyer in Q2 2019 was Capital World Investors, an estimated $91.4M added.
  • The largest Allakos seller in Q2 2019 was State Street, an estimated $22.5M sold.

Based on aggregated 13F filings for Q2 2019.